NCT05624905 Prospective Pecutaneous Coronary Intervention Registry
| NCT ID | NCT05624905 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2016-03-20 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2016-03-20 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.
Eligibility Criteria
Inclusion Criteria: * patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention. Exclusion Criteria: * patients who did not consent to the research
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05624905 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05624905 currently recruiting?
Yes, NCT05624905 is actively recruiting participants. Contact the research team at jyhahn@skku.edu for enrollment information.
Where is the NCT05624905 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05624905 clinical trial?
NCT05624905 is sponsored by Samsung Medical Center. The trial plans to enroll 15,000 participants.